Simvastatin/Ramipril/Aspirin

辛伐他汀/雷米普利/阿司匹林

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSimvastatin/Ramipril/Aspirin
Drug Alias NameAcetylsalicylic Acid/Ramipril/Simvastatin阿司匹林/雷米普利/辛伐他汀Ramipril/Simvastatin/Aspirin阿司匹林雷米普利辛伐他汀乙酰水杨酸雷米普利辛伐他汀 +[10
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitorsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzymeHMG-CoA reductaseCyclooxygenases
Therapy Area/IndicationsHypertensionCardiovascular Diseases
Global Approved IndicationsCardiovascular Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGuatemala
Original Approved Date2011/01/01
Country/TerritoryUnited StatesMexicoGuatemala
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFerrer
China Registration ClassN/A

Develop Information

Active CompaniesFerrer
Inactive CompaniesFerrer Internacional Sa
Active IndicationsCardiovascular Diseases
Inactive IndicationsHypertension

Other Information

ATC CodeC10BA
Related LinksN/A